Hemoglobin research and the origins of molecular medicine.
暂无分享,去创建一个
[1] Gonçalo R. Abecasis,et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of β-thalassemia , 2008, Proceedings of the National Academy of Sciences.
[2] M. Gladwin,et al. Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] Arthur M Lesk,et al. Structural divergence and distant relationships in proteins: evolution of the globins. , 2005, Current opinion in structural biology.
[4] L. Pauling,et al. Sickle cell anemia a molecular disease. , 1949, Science.
[5] F. Hecht,et al. HUMAN EMBRYONIC HEMOGLOBINS. , 1964, Cold Spring Harbor symposia on quantitative biology.
[6] Cameron S. Osborne,et al. Intergenic Transcription, Cell-Cycle and the Developmentally Regulated Epigenetic Profile of the Human Beta-Globin Locus , 2007, PloS one.
[7] D. Chitayat,et al. MID1 mutation screening in a large cohort of Opitz G/BBB syndrome patients: twenty‐nine novel mutations identified , 2007, Human mutation.
[8] David J Singel,et al. Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. , 2005, Annual review of physiology.
[9] Mark T Gladwin,et al. Hemoglobin and the paracrine and endocrine functions of nitric oxide. , 2003, The New England journal of medicine.
[10] P. Fraser,et al. Developmental regulation of the beta-globin gene locus. , 2005, Progress in molecular and subcellular biology.
[11] S. Liebhaber,et al. Regulation of alpha-globin mRNA stability. , 2003, Experimental biology and medicine.
[12] J. Ragoussis,et al. α‐Haemoglobin stabilising protein is a quantitative trait gene that modifies the phenotype of β‐thalassaemia , 2006 .
[13] A. Gow,et al. An erythroid chaperone that facilitates folding of alpha-globin subunits for hemoglobin synthesis. , 2007, The Journal of clinical investigation.
[14] M. Groudine,et al. Regulation of beta-globin gene expression: straightening out the locus. , 1996, Current opinion in genetics & development.
[15] A. Dean. On a chromosome far, far away: LCRs and gene expression. , 2006, Trends in genetics : TIG.
[16] F. Grosveld,et al. Three-dimensional organization of gene expression in erythroid cells. , 2008, Current topics in developmental biology.
[17] P. Gallop,et al. The glycosylation of hemoglobin: relevance to diabetes mellitus. , 1978, Science.
[18] W. Zapol,et al. Inhaled Nitric Oxide Enables Artificial Blood Transfusion Without Hypertension , 2008, Circulation.
[19] R. Benesch,et al. The mechanism of interaction of red cell organic phosphates with hemoglobin. , 1974, Advances in protein chemistry.
[20] T. Williams,et al. Haemoglobinopathies and resistance to malaria , 2003, Redox report : communications in free radical research.
[21] M. Percy,et al. Recessive congenital methaemoglobinaemia: cytochrome b5 reductase deficiency , 2008, British journal of haematology.
[22] M. Brunori,et al. A globin for the brain , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] Y. T. Lee,et al. A signaling mechanism for growth-related expression of fetal hemoglobin. , 2004, Blood.
[24] Webb Miller,et al. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update , 2007, Human mutation.
[25] S. Liebhaber,et al. Regulation of α-Globin mRNA Stability , 2003 .
[26] R. Weber,et al. Functional Properties of Neuroglobin and Cytoglobin. Insights into the Ancestral Physiological Roles of Globins , 2004, IUBMB life.
[27] P. Lane. Sickle cell disease. , 1996, Pediatric clinics of North America.
[28] F. Barton,et al. Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea. , 1995, Controlled clinical trials.
[29] H. Bunn,et al. Hemoglobin: Molecular, Genetic and Clinical Aspects , 1984 .
[30] Raffaella Origa,et al. BETA THALASSEMIA , 2018, The Professional Medical Journal.
[31] E. Rachmilewitz,et al. MEDICAL PROGRESS : β-thalassemia , 2005 .
[32] O. Platt,et al. Hydroxyurea for the treatment of sickle cell anemia. , 2008, The New England journal of medicine.
[33] D. Nathan,et al. New developments in iron chelators , 2005, Current opinion in hematology.
[34] M. Mahajan,et al. Control of beta globin genes , 2007, Journal of cellular biochemistry.
[35] J. Watson,et al. THE SIGNIFICANCE OF THE PAUCITY OF SICKLE CELLS IN NEWBORN NEGRO INFANTS , 1948, The American journal of the medical sciences.
[36] G. Stamatoyannopoulos,et al. Histone acetylation at the human beta-globin locus changes with developmental age. , 2007, Blood.
[37] Cameron S. Osborne,et al. Developmental Regulation of the β-Globin Gene Locus , 2005 .
[38] P. Mammen,et al. Molecular insights into the functional role of myoglobin. , 2007, Advances in experimental medicine and biology.
[39] Marius Wernig,et al. Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin , 2007, Science.
[40] Asha Shah,et al. Thalassemia syndromes. , 2004, Indian journal of medical sciences.
[41] R. Hill,et al. EVOLUTION OF HEMOGLOBIN. , 1964, Federation proceedings.
[42] N. Ambalavanan,et al. SNO-hemoglobin is not essential for red blood cell–dependent hypoxic vasodilation , 2008, Nature Medicine.
[43] R. Nagel,et al. Sickle-cell disease , 2004, The Lancet.
[44] V. Ingram,et al. A Specific Chemical Difference Between the Globins of Normal Human and Sickle-Cell Anæmia Hæmoglobin , 1956, Nature.
[45] D. Zwiers,et al. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[46] G. Stamatoyannopoulos,et al. Histone acetylation at the human β-globin locus changes with developmental age , 2004 .
[47] C Argote-Olivera,et al. [Sickle-cell anemia]. , 1977, La Prensa medica mexicana.
[48] J. Edsall. Understanding Blood and Hemoglobin: An Example of International Relations in Science , 2015, Perspectives in biology and medicine.
[49] Julian R. E. Davis,et al. Concurrent Sickle-Cell Anemia and α-Thalassemia: Effect on Severity of Anemia , 1982 .
[50] C. Lowrey,et al. Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce human fetal hemoglobin. , 2007, Blood.
[51] J. E. Russell. A post‐transcriptional process contributes to efficient γ‐globin gene silencing in definitive erythroid cells , 2007, European journal of haematology.
[52] B. Pace,et al. Understanding mechanisms of γ‐globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.
[53] P. Rosenberg,et al. Lineage-specific hematopoietic growth factors. , 2006, The New England journal of medicine.
[54] A. Allison,et al. Protection Afforded by Sickle-cell Trait Against Subtertian Malarial Infection , 1954, British medical journal.
[55] G. Stamatoyannopoulos. Control of globin gene expression during development and erythroid differentiation. , 2005, Experimental hematology.
[56] L. Ignarro. Nitric oxide : biology and pathobiology , 2000 .
[57] J. Krishnan,et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.
[58] A. Ultsch,et al. Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease. , 2008, Blood.
[59] G. Rodgers. 9 Pharmacological therapy , 1998 .
[60] M L Terrin,et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. , 1995, The New England journal of medicine.
[61] M. Steinberg. Predicting clinical severity in sickle cell anaemia , 2005, British journal of haematology.
[62] J. D. Engel,et al. Fine Tuning of Globin Gene Expression by DNA Methylation , 2006, PloS one.
[63] S. Fucharoen,et al. Clinical Manifestation of &bgr;-Thalassemia/Hemoglobin E Disease , 2000, Journal of pediatric hematology/oncology.
[64] Andrew J. Gow,et al. An erythroid chaperone that facilitates folding of α-globin subunits for hemoglobin synthesis , 2007 .
[65] B. Pollock,et al. National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. , 2008, Annals of internal medicine.
[66] G. Rodgers. Pharmacological therapy. , 1998, Bailliere's clinical haematology.
[67] Swee Lay Thein,et al. Molecular therapies in β‐thalassaemia , 2007, British journal of haematology.
[68] M. Sadelain,et al. Current status of globin gene therapy for the treatment of β‐thalassaemia , 2008, British journal of haematology.
[69] J. Lukin,et al. The structure--function relationship of hemoglobin in solution at atomic resolution. , 2004, Chemical reviews.
[70] A. Schechter,et al. Levels of fetal hemoglobin necessary for treatment of sickle cell disease. , 1988, The New England journal of medicine.
[71] R. Adams,et al. Pathophysiology and treatment of stroke in sickle-cell disease: present and future , 2006, The Lancet Neurology.
[72] S. Ryter,et al. Carbon monoxide in biology and medicine , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.
[73] S. Thein. Genetic modifiers of the β‐haemoglobinopathies , 2008, British journal of haematology.
[74] S. Schrier. Thalassemia: pathophysiology of red cell changes. , 1994, Annual review of medicine.
[75] A. Nienhuis. Development of gene therapy for blood disorders. , 2008, Blood.
[76] Renee F Wilson,et al. Systematic Review: Hydroxyurea for the Treatment of Adults with Sickle Cell Disease , 2008, Annals of Internal Medicine.
[77] N. Mohandas,et al. Targeted deletion of alpha-adducin results in absent beta- and gamma-adducin, compensated hemolytic anemia, and lethal hydrocephalus in mice. , 2007, Blood.
[78] J. Miller,et al. Guidelines: From artificial evolution to computational evolution: a research agenda , 2006, Nature Reviews Genetics.
[79] C. Riemer,et al. DATABASES OF HUMAN HEMOGLOBIN VARIANTS AND OTHER RESOURCES AT THE GLOBIN GENE SERVER , 2001, Hemoglobin.
[80] K. McGrath,et al. Ontogeny of erythropoiesis in the mammalian embryo. , 2008, Current topics in developmental biology.
[81] M. Perutz. Stereochemistry of Cooperative Effects in Haemoglobin: Haem–Haem Interaction and the Problem of Allostery , 1970, Nature.
[82] B. Forget. Molecular Basis of Hereditary Persistence of Fetal Hemoglobin , 1998, Annals of the New York Academy of Sciences.
[83] M. Sadelain. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia , 2006, Current opinion in hematology.
[84] J. Neel. The Inheritance of Sickle Cell Anemia. , 1949, Science.
[85] E. Henry,et al. Evolution of allosteric models for hemoglobin , 2007, IUBMB life.
[86] G. Stamatoyannopoulos,et al. The molecular basis of blood diseases , 1987 .
[87] A. Schechter,et al. Fetal hemoglobin silencing in humans. , 2006, Blood.
[88] M. Groudine,et al. Regulation of β-globin gene expression: straightening out the locus , 1996 .
[89] Max F. Perutz,et al. Science Is Not a Quiet Life: Unravelling the Atomic Mechanism of Haemoglobin , 1998 .
[90] M. Perutz,et al. Three-dimensional Fourier Synthesis of Horse Oxyhaemoglobin at 2.8 Å Resolution: The Atomic Model , 1968, Nature.
[91] O. Doumbo,et al. Malaria and the Red Cell , 1982, The Lancet.
[92] K. McIntyre,et al. Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. , 1984, The New England journal of medicine.
[93] M. Gobbi,et al. Understanding α‐Globin Gene Regulation: Aiming to Improve the Management of Thalassemia , 2005, Annals of the New York Academy of Sciences.
[94] J. Stockman. Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death: A Meta-analysis , 2010 .
[95] Y. Kan,et al. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia. , 1982, The New England journal of medicine.
[96] M. Brunori,et al. Enzyme Proteins. (Book Reviews: Hemoglobin and Myoglobin in Their Reactions with Ligands) , 1971 .
[97] Rm,et al. Sickle cell disease , 1996 .
[98] M. Gladwin,et al. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. , 2007, Blood reviews.
[99] M. Colonna,et al. NK cell-activating receptors require PKC-theta for sustained signaling, transcriptional activation, and IFN-gamma secretion. , 2008, Blood.
[100] R. Ghirlando,et al. Chromatin boundaries and chromatin domains. , 2004, Cold Spring Harbor symposia on quantitative biology.
[101] Malte Kelm,et al. The emerging biology of the nitrite anion , 2005, Nature chemical biology.
[102] D. Higgs,et al. Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies. , 2005, Blood.
[103] M. Perutz. Stereochemistry of cooperative effects in haemoglobin. , 1970, Nature.
[104] R. Winslow. The role of hemoglobin oxygen affinity in oxygen transport at high altitude , 2007, Respiratory Physiology & Neurobiology.
[105] M. Perutz,et al. Molecular Pathology of Human Haemoglobin , 1968, Nature.
[106] Xiaowu Gai,et al. A GATA-1-regulated microRNA locus essential for erythropoiesis , 2008, Proceedings of the National Academy of Sciences.
[107] Swee Lay Thein,et al. Genetic insights into the clinical diversity of β thalassaemia , 2004, British journal of haematology.
[108] Melanie J Percy,et al. Disorders of oxidised haemoglobin. , 2005, Blood reviews.
[109] A. Bank. Regulation of human fetal hemoglobin: new players, new complexities. , 2006, Blood.
[110] M. Cappellini,et al. Thalassemia intermedia: revisited. , 2006, Blood cells, molecules & diseases.
[111] Richard Earl Dickerson,et al. Hemoglobin : structure, function, evolution, and pathology , 1983 .
[112] Kirby D. Johnson,et al. Establishment and regulation of chromatin domains: mechanistic insights from studies of hemoglobin synthesis. , 2006, Progress in nucleic acid research and molecular biology.
[113] Arthur W. Nienhuis,et al. Hemoglobin switching , 1978, Cell.
[114] J. Clegg,et al. The interaction of alpha-thalassemia and homozygous sickle-cell disease. , 1982, The New England journal of medicine.
[115] Simon Heath,et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15 , 2007, Nature Genetics.
[116] S. Orkin,et al. The transcriptional control of hematopoiesis. , 1996, Blood.
[117] J. Ragoussis,et al. Alpha-haemoglobin stabilising protein is a quantitative trait gene that modifies the phenotype of beta-thalassaemia. , 2006, British journal of haematology.
[118] D. Loukopoulos,et al. Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia. , 2001, Seminars in hematology.
[119] S. Orkin,et al. Regulation of globin gene expression in erythroid cells. , 1995, European journal of biochemistry.
[120] S. Thein,et al. Molecular diagnosis of haemoglobin disorders. , 2004, Clinical and laboratory haematology.
[121] A. Schechter,et al. Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease , 2001, Current opinion in hematology.
[122] G. Felsenfeld,et al. Insulators: exploiting transcriptional and epigenetic mechanisms , 2006, Nature Reviews Genetics.
[123] Chris P. Miller,et al. MicroRNA expression dynamics during murine and human erythroid differentiation. , 2007, Experimental hematology.
[124] G. Lucarelli,et al. Advances in the allogeneic transplantation for thalassemia. , 2008, Blood reviews.
[125] Y. Kan,et al. Polymorphism of DNA sequence adjacent to human beta-globin structural gene: relationship to sickle mutation. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[126] Xiangdong Fang,et al. Locus control regions. , 2002, Blood.
[127] M. Perutz,et al. X-Ray Analysis of HæMoglobin , 1942, Nature.